Skip to main content

SQ, TDOC, VRTX: Cathie Wood is optimistic about doubling stocks


When Cathie Wood buys stocks, investors will follow her to buy, which seems to be the latest trend in the investment world.

 In the popular saying, following Cathie Wood, there is money to be made.  Even some time ago due to the rise in U.S. Treasury yields, technology stocks plummeted, and ARK funds suffered a frantic sell-off. Wood is still as stable as a mountain, and he issued a statement saying that everything was as early as we expected and was better than we expected.  Technology stocks are a good time to buy bottoms and increase positions.  Today, I will analyze Cathie Wood's heavy holdings from the company's fundamentals and future market prospects. Can it double in the long run?

 Square (ranked first in ARKK's innovative technology ETF)

 The financial technology giant Square is a revolutionary stock in the financial industry, breaking the traditional payment industry.  Square is known for its seller ecosystem, which provides small businesses with point-of-sale solutions and analytical tools.  In return, Square collects merchant fees as revenue from the gross payment volume (Gross Payment Volume, GPV) of the network.  Between 2012 and 2019, this GPV soared from US$6.5 billion to US$106.2 billion.  Although GPV may decline in 2020 due to the epidemic, the compound annual growth rate from 2012 to 2019 is 49%, indicating that it will return to its previous level in 2021.

 It is worth noting that the Square seller ecosystem has been very effective in attracting larger merchants in recent years.  Merchants with an average annual GPV of at least US$125,000 in the third quarter of 2020 accounted for 61% of the total GPV.  Because this is a merchant fee-driven business, so more large companies use the platform to make Square make more money.  Cash App had more than 36 million active users in the fourth quarter, an increase of 50% over the same period last year.  Square is also gradually increasing the features available on the Cash App, making it more and more popular for individuals to conduct a wide range of financial transactions.

 Of course, Square's peer-to-peer payment platform Cash App provides the largest amount of business.  As millennials promote more digital payment methods, the monthly active user base of Cash App has surged (7 million at the end of 2017 and 30 million by mid-2020).  Cash App provides Square with a variety of income collection methods, including payment transfer fees, merchant fees, investment, and bitcoin exchange fees.  Cash App should become the main driver of the company's gross profit in 2021.

 Overall, Square is a value growth stock.  The company's current market value is about 103 billion US dollars, which is equivalent to 196 times PE and 7.8 times PS.

 Square achieved initial success by providing payment processing services for small and medium businesses.  Over time, the company expanded its products and services to include point-of-sale software, e-commerce platforms, payroll services, business debit cards, etc.  Starting this month, Square now also operates a federally chartered bank.  This opened the door for Square to provide small business loans to its customers.

 The current transition from cash to digital payment is still in its infancy.  Square is expected to grow through its sellers and Cash App ecosystem, and in the process will bring substantial benefits to investors.

 Teladoc Health (Leader in Telemedicine)

 Due to the epidemic, the development of telemedicine has made real progress in 2020.  Teladoc Health is one of the biggest winners.  Its stock price soared by nearly 140%.

 However, so far, TDOC is still in the early stages of telemedicine.  According to data, after the epidemic is over, the annual telemedicine market in the United States will grow to about 250 billion US dollars. If the international market is added, this number will be even greater, and TDOC will be less than 30 billion US dollars.  There is still enough space.

 TDOC should be the biggest beneficiary among them.  Although Amazon announced plans to launch Amazon Care telemedicine services to its American employees this summer.  Amazon also intends to provide the service to other companies later in 2021 to participate in the competition in the telemedicine market.  But Mu Ji disagrees, thinking that Amazon will not pose a threat to TDOC.  Continue to increase TDOC.

 Sister Mu believes that TDOC is the global leader in virtual care.  So far, more than 40% of Fortune 500 companies use TDOC's services, and it provides more comprehensive products than its competitors.  The most important thing is that the growth prospects of TDOC are very broad, and the development space of telemedicine is large enough.  Coupled with TDOC's acquisition of Livongo Health, which operates a digital health platform that can help individuals manage chronic diseases, which creates a huge cross-selling opportunity.

 Vertex Pharmaceuticals

 ARK Genomic Revolution ETF ranked sixth

 Vertex Pharmaceuticals (VRTX) is currently the strongest performer among all the top stocks of Wood's ETF.  Large biotech companies do not have any competitors in their core markets.  Vertex's four approved cystic fibrosis drugs are the only drugs that treat the underlying cause of genetic diseases.

 Vertex also uses its expertise to target other rare genetic diseases.  It expects to report the key results of a Phase 2 study evaluating VX-864 in the treatment of liver disease alpha-1 antitrypsin deficiency in the next few months.  The company's product line also includes candidates for rare blood diseases β thalassemia and sickle cell disease and rare kidney disease focal segmental glomerulosclerosis.

 And Vertex has the potential to change conventional treatment methods, and this treatment has just entered Phase 1/2 research.  If the cell therapy VX-880 succeeds in clinical trials, it may be able to enable type 1 diabetes patients to live independently of insulin.

 Vertex has a cash reserve of 6.6 billion U.S. dollars and plans to use it to recruit mid- and late-stage candidates to further strengthen its product line.  In the next few years, this biotech stock will continue to be a big winner.  In the long run, both financial technology and telemedicine are closely related to people’s lives. These are the general trends in which people’s living habits are being reshaped and the new trends in future technological development. These general trends may be in the next few decades.  In the span, change the global social, economic, and political landscape.  It is believed that investors will continue to benefit from these changes and generate high returns.

Comments

Popular posts from this blog

VRTX stock forecast 2025: Vertex is undervalued

Let's look at some biotech companies with stable cash flow and currently undervalued value stocks as targets for diversified portfolios.  The company I shared today, called Vertex Pharmaceuticals (VRTX), is dedicated to the development of rare diseases, especially Cystic Fibrosis (CF). I have always had high respect for the rare disease group of pharmaceutical companies in the disease category. In addition, in the future, gene and cell therapies are subverting the role of rare diseases in the pharmaceutical industry, making rare diseases no longer uncommon. It's tasteless, but a field full of the future. Vertex Pharmaceuticals Inc. was established in 1989 by Joshua Boger and Kevin Kinsella. is headquartered in Boston. At that time, several very good research and development companies were established in the United States, including the aforementioned Regeneron, Gilead, and today's Vertex.  Vertex In the past, he devoted himself to the development of small molecule drugs, wh...

Investors have begun to switch back to traditional growth stocks

 On Thursday, the stock prices of Cisco, Alphabet, and IBM hit new highs. But more importantly, the previously unpopular speculative growth stocks, including stocks bought by many ARK funds, have now begun to rebound.  How is this going?  Investors' perspective on the market is changing. In the first quarter of this year, mainstream voices in the market believe that the economy will restart strongly, bond yields will rise, and inflation may become a problem later this year. After the end of the first quarter, these expectations were only partially fulfilled.  The U.S. economy has indeed restarted strongly, but bond yields fell in the first quarter instead of rising because investors began to believe:  1) Inflation and supply chain disruption may indeed be "temporary", as the Fed insists;  2) The second and third quarters will be the highest points of stock returns and economic growth.  Alec Young, a chief investment officer of Tactical Alpha, said: “...

Bitcoin crashed! In a word of Musk, the digital currency plummeted!

Ethereum is thriving, what logic?  The world's second-largest digital currency, Ethereum, is continuing to challenge the influence of Bitcoin by its "functionality".  On the morning of May 13th, the price of Bitcoin plummeted by more than 13% and once fell below the $50,000 mark. As a challenger to Bitcoin, Ethereum fell by about 8% and continued to narrow its decline. The previous day, Ether  The market rose by 6% during the intraday session, with a market value exceeding US$500 billion, and its price hitting a record high.   In the past 6 months, the price of Ethereum has risen by as much as 8 times, out of the independent market, has far outperformed the continued consolidation of Bitcoin.  At present, the share of Ethereum in digital currencies' total global market value has risen to 18%, while the weight of Bitcoin's market value has been cut in the past two years, and the current market value has dropped to 38%.  On the morning of May 13, there w...

BABA stock forecast 2025: The failure of Ant Financial's IPO

Ant Financial’s IPO was canceled, causing Alibaba’s share price to fall, Alibaba has been unfavorable this year. First, the cancellation of Ant Financial's IPO indirectly caused Alibaba's stock price to fall, and now there is an antitrust investigation led by Alibaba, which caused Alibaba's stock price to plummet by 15% in a single day. From the highest point in October, the stock price of 319 dollars has fallen by as much as 30% to 222 dollars. From the perspective of K-line, Alibaba has reached the Oversold area, and it will rebound upward in the short term. From the perspective of valuation, Alibaba’s valuation is as high as US$388, which is 74% of the current share price of US$222. Value-added space, so it seems that whether it is viewed from the short-term K-line or the long-term valuation, now is a good time to buy the bottom of Alibaba. Before investing, I will analyze and analyze the root cause of the disadvantage of Alibaba this time, because if this problem is not...

ASML stock forecast 2025: is it time to buy now?

Hello everyone, recently, because the market has a lot of fears about rising interest rates and shrinking the balance sheet, the Nasdaq as a whole has fallen a lot, and each support has basically been broken one after another. The general price has also broken, so there is no good signal to increase positions in the short term. It may be safer to hold cash first and wait until the decline begins to slow down a little or see a really cost-effective price before considering adding positions. However, the long-term bull market in the future will not end because of this year's interest rate hike, and cash will only become more and more worthless in the long run. In the short-term continuous decline of the stock market, we must put our minds in a positive state. At the same time, we must properly organize our thoughts and positions, prepare bullets, and use this time to do our homework for the stocks we are interested in. In this way, when a good price appears in the future, you will be...

Will China's economy recover as the epidemic is under control?

During the Chinese Spring Festival, novel coronavirus broke out in Wuhan, and the Chinese stock market was hit hard. Subsequently, the Chinese government quickly took strict measures to block Wuhan, a city with a population of tens of thousands of people, to prevent the further spread of the epidemic, and to take corresponding epidemic prevention measures in other cities.  When the worst of the epidemic had already occurred, the Chinese stock market quickly rebounded. As the number of infections continues to decline, China's Shanghai Composite Index is expected to rise further. Sars Period Looking back on similar events in the past, the SARS epidemic in 2003, the stock market also made a short-term decline, and then the SARS epidemic was brought under control, the stock market immediately went up for a long time. According to past historical data, the impact of the novel coronavirus epidemic on the stock market may be short-lived. China Fund Capital Flow Howeve...

AMD stock forecast 2025: Q2 is expected to perform strongly

Before the US stock market on July 19, US technology stocks continued their decline last Friday, and AMD's stock price also continued to fall.  AMD will announce the results of the second quarter of 2021 on July 27. The market expects this performance to be strong, so this round of decline may be a great opportunity to buy the stock.  financial indicator  Due to the strong market demand for CPU and graphics cards in 2021, AMD’s revenue is expected to exceed the maximum value of the financial guidance. AMD’s C&G business is expected to grow the most because higher-priced AMD Ryzen and high-end AMD Radeon sales continue to increase.  In terms of gross profit margin, the market expects AMD's gross profit margin in Q2 2021 will increase by 47% year-on-year.  If the average selling prices of CPUs and GPUs continue to rise in Q2 of 2021, and the ASPs of CPUs and GPUs will increase in Q1 of 2021, the gross profit margin may also increase by 48%.  CPU market sh...

Teladoc stock forecast 2025: Is it time to buy TDOC?

 TDOC's performance exceeded expectations. Why did the performance decline after the announcement?  Teladoc (TDOC) reported quarterly earnings of US$0.13 per share, which exceeded the consensus estimate of a loss of US$0.57 per share. In the same period last year, it had a loss of US$0.4 per share.  The earnings of this financial report far exceeded expectations.  In the last quarter, people expected this telemedicine service company to lose 0.25 US dollars per share, but the actual loss per share was 0.27 US dollars, which was not as good as expected at the time.  In the past four quarters, TDOC exceeded expectations twice.  The management stated that the company's current momentum in various channels and regions should not be underestimated in the conference call. It has raised its annual revenue guidance to 20 million U.S. dollars, which is expected to be between 1.97 billion and 2.02 billion U.S. dollars.    In the first quarter, the comp...

Will the Great Depression make a comeback?

the Great Depression On March 21, 2020, the United States already had initial unemployment data. Exceeding market expectations, the number of applicants reached 3.28 million, a record high. The current unemployment situation in the United States. Before March 7, employment in the United States was not affected by the epidemic. In the week of March 7, the number of people applying for unemployment benefits for the first time in the United States was 211,000, a decrease of 4,000 compared to the previous week. It is still healthy. This shows that the United States is in a good employment track range. The actual data began to fluctuate, that is, the data for the week of March 14, the number of people applying for relief reached 282,000, a slight increase. On March 21, the number of people applying for unemployment benefits soared to a record high this week. 1.7 million people have far exceeded expectations, and market expectations are about 1.5 to 1.7 million people. It can be said...

Bear market coming, gold(GLD) assets become essential

The economic data of the global economic powers have been deteriorating, entering the bear market stage of the economy, and people have become more cautious when choosing asset investment. We should choose investment products with a low correlation coefficient with economic performance and investment products suitable for the current economic cycle. Investors should pay more attention to foreign exchange and commodity markets so that they can add value to your assets. Among many assets, anti-inflation commodities such as gold have become essential assets. Take gold as an example. For many years, gold has been regarded as an anti-inflation commodity by international capital markets and has been regarded as an important asset hedging tool by investors. There is also a saying, "The world bought gold during turbulent times." From basic political theory, we know that gold is not currency, and the currency is naturally gold and silver. Although gold has withdrawn from ...